首页> 外文期刊>Molecular pharmacology. >Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure.
【24h】

Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure.

机译:在转基因小鼠中以血管靶向的G蛋白偶联受体激酶2的过表达减弱了β-肾上腺素受体信号传导并增加了静息血压。

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiovascular regulation is tightly controlled by signaling through G protein-coupled receptors (GPCRs). beta-Adrenergic receptors (ARs) are GPCRs that regulate inotropy and chronotropy in the heart and mediate vasodilation, which critically influences systemic vascular resistance. GPCR kinases (GRKs), including GRK2 (or betaARK1), phosphorylate and desensitize agonist-activated betaARs. Myocardial GRK2 levels are increased in heart failure and data suggest that vascular levels may also be elevated in hypertension. Therefore, we generated transgenic mice with vascular smooth muscle (VSM) targeted overexpression of GRK2, using a portion of the SM22alpha promoter, to determine its impact on vascular betaAR regulation. VSM betaAR signaling, as determined by adenylyl cyclase and mitogen-activated protein (MAP) kinase activation assays, was attenuated when GRK2 was overexpressed 2- to 3-fold. In vivo vasodilation in response to betaAR stimulation using isoproterenol was attenuated and conscious resting mean arterial blood pressure was elevated from 96 +/- 2 mm Hg in nontransgenic littermate control (NLC) mice (n = 9) to 112 +/- 3 mm Hg and 117 +/- 2 mm Hg in two different lines of SM22alpha-GRK2 transgenic mice (n = 7 and n = 5, respectively; p < 0.05). Interestingly, medial VSM thickness was increased 30% from 29.8 +/- 1.6 microm in NLC mice (n = 6) to 39.4 +/- 1.6 microm in SM22alpha-GRK2 mice (n = 7) (p < 0.05) and vascular GRK2 overexpression was sufficient to cause cardiac hypertrophy. These data indicate that we have developed a unique mouse model of hypertension, providing insight into the contribution that vascular betaAR signaling makes toward resting blood pressure and overall cardiovascular regulation. Moreover, they suggest that GRK2 plays an important role in vascular control and may represent a novel therapeutic target for hypertension.
机译:通过G蛋白偶联受体(GPCR)发出的信号来严格控制心血管调节。 β-肾上腺素能受体(ARs)是GPCR,可调节心脏的正性变力和变时性并介导血管舒张,从而严重影响全身性血管阻力。包括GRK2(或betaARK1)在内的GPCR激酶(GRK)使磷酸化激动剂激活的betaARs并使之脱敏。心力衰竭时心肌GRK2水平升高,数据表明高血压中血管水平也可能升高。因此,我们使用部分SM22alpha启动子生成了具有血管平滑肌(VSM)靶向的GRK2过表达的转基因小鼠,以确定其对血管betaAR调控的影响。当GRK2过表达2到3倍时,通过腺苷酸环化酶和丝裂原激活的蛋白(MAP)激酶激活测定确定的VSM betaAR信号转导减弱。使用异丙肾上腺素对βAR刺激的体内血管舒张作用减弱,有意识的静息平均动脉血压从非转基因同窝对照(NLC)小鼠(n = 9)的96 +/- 2 mm Hg升高到112 +/- 3 mm Hg SM22alpha-GRK2转基因小鼠的两个不同品系中分别为117 +/- 2 mm Hg(n = 7和n = 5; p <0.05)。有趣的是,内侧VSM厚度增加了30%,从NLC小鼠(n = 6)的29.8 +/- 1.6微米增加到SM22alpha-GRK2小鼠(n = 7)的39.4 +/- 1.6微米(p <0.05)和血管GRK2过表达足以引起心脏肥大。这些数据表明,我们已经开发出独特的高血压小鼠模型,从而洞察了血管betaAR信号传导对静息血压和整体心血管调节的作用。此外,他们表明,GRK2在血管控制中起着重要作用,并且可能代表高血压的新治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号